|
| Home : Squarex Announces Positive Results from Completed Phase 2 Study of SQX770 in the Prevention of Recurrent Herpes Labialis |
|
Aug 05
2019 |
Squarex Announces Positive Results from Completed Phase 2 Study of SQX770 in the Prevention of Recurrent Herpes Labialis |
|
ST. PAUL, Minn., Aug. 5, 2019 /PRNewswire/ -- Squarex, a clinical-stage pharmaceutical company developing a topical immunomodulator for the long-term prevention of recurrent cold sores and other infections caused by herpes simplex viruses, today announced positive results from a Phase 2... |
|
|
|
| Source:https://www.prnewswire.com:443/news-releases/squarex-announces-positive-results-from-completed-phase-2-study-of-sqx770-in-the-prevention-of-recurrent-herpes-labialis-300896065.html |
| |
|
Related News
|
» La plataforma de compra de realidad aumentada Point & Place® añade sindicación WebAR
» Cars.com Reports Second Quarter 2019 Results
|
|
|
